Quest Diagnostics (NYSE:DGX) Price Target Increased to $150.00 by Analysts at UBS Group

Retrieved on: 2022-04-24 15:06:41

Tags for this article:

Click the tags to see associated articles and topics

Quest Diagnostics (NYSE:DGX) Price Target Increased to $150.00 by Analysts at UBS Group. View article details on hiswai:

Excerpt

Morgan Stanley cut their price target on shares of Quest Diagnostics from $159.00 to $145.00 and set an “equal weight” rating on the stock in a ...

Article found on: www.defenseworld.net